Bolt BiotherapeuticsBOLT
13F holders, Q1 2025 (March 31)30holders −8
2new positions
10sold out
1famous investor
$0.40avg. 13F price*
At the end of Q1 2025, 30 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings, down 8 from Q4 2024. 2 opened new positions and 10 sold out. The largest holders were Tang Capital Management LLC ($1.5M), Vivo Capital, LLC ($1.4M) and Sofinnova Investments, Inc. ($1.1M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702104
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $15K |
| Exits | 10 | $243K |
All 13F filers, Q4 2024 → Q1 2025: 276,104 shares bought and 605,279 shares sold, net −329,175 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Tang Capital Management LLC | 0.08% | No change | 3,812,773 | $1.5M |
| Vivo Capital, LLC | 0.19% | No change | 3,521,291 | $1.4M |
| Sofinnova Investments, Inc. | 0.08% | No change | 2,754,437 | $1.1M |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.61% | No change | 1,891,467 | $757K |
| Vanguard Group Inc. | 0.00% | Add +9.6% | 1,169,705 | $468K |
| Nan Fung Group Holdings Ltd | 0.38% | No change | 1,166,952 | $467K |
| Samsara Biocapital, LLC | 0.07% | No change | 1,049,153 | $420K |
| Board of Trustees of The Leland Stanford Junior University | 0.02% | No change | 719,546 | $288K |
| Pfizer Inc | 0.05% | No change | 626,109 | $250K |
| Geode Capital Management, LLC | 0.00% | Add +10.1% | 375,113 | $150K |
| Renaissance Technologies | 0.00% | Add +4.0% | 314,139 | $126K |
| BlackRock, Inc. | 0.00% | Reduce -0.5% | 268,640 | $107K |
| ADAR1 Capital Management, LLC | 0.02% | No change | 244,966 | $98K |
| UBS Group AG | 0.00% | Add +68.7% | 111,508 | $45K |
| Squarepoint Ops LLC | 0.00% | Add +71.3% | 83,893 | $34K |
| State Street Corp. | 0.00% | No change | 47,437 | $19K |
| Northern Trust Corp. | 0.00% | No change | 40,895 | $16K |
| Mariner, LLC | 0.00% | Add +14.3% | 40,000 | $16K |
| Susquehanna International Group, LLP | 0.00% | New | 21,733 | $9K |
| StoneX Group Inc. | 0.00% | New | 15,532 | $6K |
| XTX Topco Ltd | 0.00% | Reduce -65.7% | 15,392 | $6K |
| Morgan Stanley | 0.00% | Reduce -0.0% | 11,615 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +116.8% | 8,688 | $3K |
| FMR LLC | 0.00% | Reduce -93.7% | 8,100 | $3K |
| Bank of America Corp. | 0.00% | Add +0.1% | 5,628 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -0.6% | 906 | $362 |
| SBI Securities Co., Ltd. | 0.00% | No change | 200 | $80 |
| Barclays PLC | 0.00% | No change | 139 | $56 |
| Salem Investment Counselors Inc. | 0.00% | No change | 40 | $16 |
| BNP Paribas Financial Markets | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.